The Indicator from Planet Money The Indicator from Planet Money

Why doesn't the US have better sunscreen?

Jul 20, 2026 · 9m

Summary

Charlotte Palomino discusses the U.S. sunscreen shortage caused by FDA regulations that classify sunscreens as drugs. The episode highlights the recent approval of the ingredient bemetrizone after decades of delay and political advocacy. Economist Alex Tabarrok argues the FDA is overly risk-averse, proposing "peer approval" to accept safety standards from other countries. This regulatory caution may inadvertently increase skin cancer rates by limiting access to effective products.

Topics discussed

Introduction to Charlotte Palomino and the US sunscreen problem Show intro and sponsor messages Skincare advice and low daily sunscreen usage stats Advocacy efforts and the long FDA approval process Legislative changes and approval of Bimetrizonol Economic analysis of FDA risk aversion and peer approval FDA response, new product plans, and show credits Closing sponsor messages

More from The Indicator from Planet Money

Tech blackouts, Black Friday fake-outs, and C-suite tariff cash-outs
Nov 20, 2026
Why the 'good old days' of American manufacturing are long gone
Nov 19, 2026
We got this economics podcast before GTA VI
Nov 18, 2026
How a tribal water deal could put a price tag on the Colorado River
Nov 17, 2026
Three influencer types and how they generate money
Nov 16, 2026
Listen ad-free on Castria